In the US, Daptomycin (daptomycin systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Bacteremia, Endocarditis, Methicillin-Resistant Staphylococcus Aureus Infection, Skin and Structure Infection and Skin or Soft Tissue Infection.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
N-(1-Oxodecyl)-L-tryptophyl-Lasparaginyl-L-alfa-aspartyl-L-treonylglycyl-L-ornityl-L-alfa-aspartyl-D-alanyl-L-alfa-aspartylglycyl-D-seryl-treo-3-metyl-L-alfa-glutamyl-gamma-(2-amminophenyl)-gamma-oxo-L-alfa-aminobutanoic acid epsilon1-lactone
- Daptomycinum (Latin)
- Daptomycin (German)
- Daptomycine (French)
- Daptomicina (Spanish)
- Daptomycin (OS: USAN, BAN, JAN)
- LY-146032 (IS: Lilly)
AstraZeneca, China; AstraZeneca, Hong Kong; AstraZeneca, Malaysia; AstraZeneca, Philippines; AstraZeneca, South Africa; AstraZeneca Singapore, Singapore; Cardinal Health, Taiwan; Cubist, Israel; Cubist, United States; Hospira Inc., Vietnam; MSD, Japan; Novartis, Argentina; Novartis, Chile; Novartis, Finland; Novartis, France; Novartis, Greece; Novartis, Croatia (Hrvatska); Novartis, Ireland; Novartis, Iceland; Novartis, Lithuania; Novartis, Norway; Novartis, New Zealand; Novartis, Poland; Novartis, Romania; Novartis, Sweden; Novartis, Slovakia; Novartis, Turkey; Novartis Europharm, Austria; Novartis Europharm, Cyprus; Novartis Europharm, Denmark; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals UK, United Kingdom; Sunovion Pharmaceuticals, Canada; TTY Biopharm, Taiwan
|BAN||British Approved Name|
|IUPAC||International Union of Pure and Applied Chemistry|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.